Air Products & Chemicals vs Linde
APD and LIN side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How APD and LIN compare
Linde is the larger company, worth 3.4 times as much as Air Products & Chemicals ($237B against $70.5B).
Linde grew revenue faster over the last twelve months (8.2% versus 4.5% for Air Products & Chemicals).
Linde keeps more of each dollar of sales as profit, with a net margin of 19.3% compared with −0.38% at Air Products & Chemicals.
Both pay dividends: Air Products & Chemicals yields 2.3% and Linde 1.2%.
Linde scores higher on the StockData Score (16 against 10 for Air Products & Chemicals), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | APD | LIN |
|---|---|---|
| Size and price | ||
| Market cap | $70.5B | $237B |
| Share price | $316.43 | $514.24 |
| Change, 1 year | 27.4% | 19.0% |
| Change, 5 years | 2.3% | 54.9% |
| Beta (5Y) | 0.71 | 0.59 |
| Employees | 21K | 65K |
| StockData Score | ||
| Total score | 10 | 16 (better) |
| Valuation score | 0 | 1 (better) |
| Growth score | 2 | 3 (better) |
| Performance score | 2 | 5 (better) |
| Health score | 4 (better) | 3 |
| Dividend score | 2 | 4 (better) |
| Valuation | ||
| P/E | – | 34.1× |
| P/S | 5.6× (better) | 6.5× |
| P/B | 5.1× (better) | 6.0× |
| EV/EBITDA | 76.9× | 20.1× (better) |
| P/FCF | – | 46.7× |
| PEG | – | 1.62 |
| FCF yield | −0.43% | 2.1% (better) |
| Fair value | $94.33 | $376.08 |
| Margin of safety | −235% | −36.7% (better) |
| Growth | ||
| Revenue growth (TTM) | 4.5% | 8.2% (better) |
| Revenue growth, 5Y average | 6.3% (better) | 4.5% |
| Net income growth (TTM) | −103% | −1.2% (better) |
| EPS growth (TTM) | −103% | 0.87% (better) |
| EPS growth, 5Y average | – | 25.4% |
| Profitability | ||
| Gross margin | 32.1% | 47.9% (better) |
| Operating margin | −4.7% | 25.3% (better) |
| Net margin | −0.38% | 19.3% (better) |
| FCF margin | −2.4% | 14.0% (better) |
| Return on equity | −0.32% | 18.0% (better) |
| Return on invested capital | −3.3% | 11.5% (better) |
| Financial health | ||
| Debt / equity | 0.06 (better) | 0.68 |
| Net debt / EBITDA | −0.09 | 1.75 (better) |
| Interest coverage | −2.7× | 35.5× (better) |
| Current ratio | 1.08 (better) | 0.86 |
| Altman Z-score | 2.61 | 4.06 (better) |
| Piotroski F-score | 4 | 7 (better) |
| Dividends and buybacks | ||
| Dividend yield | 2.3% (better) | 1.2% |
| Payout ratio | – | 41.6% |
| Years of dividend growth | 16 (better) | 9 |
| Dividend growth, 5Y average | 6.6% | 9.3% (better) |
| Buyback yield | – | 1.7% |
| Shareholder yield | 2.3% | 2.9% (better) |
| Ownership | ||
| Held by institutions | 91.3% | 85.3% |
| Held by insiders | 0.44% | 0.20% |
| Insider net buying, 12 months | −$20.8M | −$11.8M (better) |
| Superinvestors holding | 2 | 6 (better) |
| Short interest, % of float | 2.3% | 1.3% |
Go deeper
- APD stock overview
- APD income statement
- APD valuation and score
- LIN stock overview
- LIN income statement
- LIN valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.